Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Peripheral Artery Disease Market Revenue Outlook: What CAGR Is Expected Through 2030?

The market for peripheral artery disease treatments has demonstrated robust expansion recently, projected to increase from $4.62 billion in 2025 to $4.97 billion in 2026, reflecting a compound annual growth rate of 7.5%. This historical growth trajectory has been propelled by factors such as the widespread occurrence of peripheral artery disease, a general lack of awareness regarding its risk factors, a predominant reliance on conventional pharmaceutical approaches, insufficient availability of interventional specialists, and the disjointed nature of patient care processes.

The market for peripheral artery disease is poised for significant expansion, projected to reach $6.69 billion by 2030, exhibiting a compound annual growth rate of 7.8% during the forecast period. This upward trajectory is fueled by several key factors, including the continuous innovation in minimally invasive surgical techniques, the increasing utilization of drug-eluting balloons and stents, the proliferation of hospitals and specialized vascular treatment centers, heightened public awareness coupled with proactive early detection programs, and the growing prevalence of combination treatment strategies that incorporate both lifestyle adjustments and pharmacological interventions. Furthermore, several prominent trends are anticipated to shape this market, such as the escalating application of artificial intelligence for the early identification and risk assessment of peripheral artery disease, a greater embrace of cloud-based systems for patient health monitoring, a heightened emphasis on personalized treatment approaches guided by genetic insights, the enhanced integration of Internet of Things (IoT) devices for monitoring patients after interventions, and the broader implementation of intelligent manufacturing processes in the production of medical devices for peripheral artery disease.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12068&type=smp

Peripheral Artery Disease Market Expansion Supported By Key Demand Factors

An increasing incidence of peripheral artery diseases is anticipated to fuel the expansion of the peripheral artery disease market, given that peripheral artery disease signifies the constriction or obstruction of arteries beyond the heart, predominantly in the legs, leading to diminished blood flow and potential adverse outcomes. Treatments for peripheral artery disease are designed to alleviate symptoms, improve mobility, and mitigate the likelihood of serious complications, thereby enhancing patient health. As an illustration, data from the American Heart Association, a non-profit entity based in the United States, indicated in June 2023 that an estimated 7 to 12 million Americans and 200 million individuals worldwide suffer from this condition. Consequently, the escalating prevalence of peripheral artery diseases is serving as a catalyst for the growth observed in the peripheral artery disease market.

Peripheral Artery Disease Market Categorization By Product Type And Application

The peripheral artery disease market covered in this report is segmented –

1) By Type: Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories

2) By Drugs: Lipid-Lowering Drugs, Blood Pressure Lowering Drugs, Glucose Regulating Drugs, Blood Clot Preventing Drugs, Inotropes, Thrombolytics Agents, Anti-Inflammatory Agents

3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations

4) By End Users: Hospitals, Specialty Clinics, Other End Users

Subsegments:

1) By Peripheral Angioplasty Balloons: Drug-Eluting Balloons, Non-Drug-Eluting Balloons, Scoring Balloons, Cutting Balloons

2) By Peripheral Stents: Drug-Eluting Stents, Bare Metal Stents, Covered Stents

3) By Peripheral Catheters: Sheath Introducers, Guidewires, Diagnostic Catheters, Delivery Catheters

4) By Inferior Vena Cava (IVC) Filters: Retrievable IVC Filters, Permanent IVC Filters

5) By Plaque Modification Devices: Atherectomy Devices, Laser Atherectomy Devices, Rotational Atherectomy Devices

6) By Hemodynamic Flow Alteration Devices: Flow Diversion Devices, Flow Restriction Devices

7) By Peripheral Accessories: Diagnostic Imaging Accessories, Accessory Kits For Interventional Procedures, Support Devices

Peripheral Artery Disease Market Growth Trends Influencing Competitive Dynamics

In the competitive peripheral artery disease (PAD) market, leading entities are prioritizing the creation of novel treatments, exemplified by drug-eluting scaffold systems that can be absorbed by the body. This innovation directly addresses the increasing need for safer, longer-lasting, and minimally invasive methods to treat blockages in arteries below the knee. Such bioresorbable scaffold technologies are engineered to re-establish blood circulation before gradually disappearing, presenting a significant benefit compared to conventional metal stents that remain permanently implanted. A notable development occurred in April 2024 when Abbott Laboratories, a prominent U.S. medical technology firm, launched the Esprit BTK Everolimus Eluting Resorbable Scaffold System. This groundbreaking dissolvable stent therapy is specifically designed for PAD located below the knee, administering everolimus to curb vessel re-stenosis while its entirely resorbable nature allows it to dissolve naturally, thereby mitigating the long-term risks tied to metallic implants. It represents a sophisticated option for clinicians, superseding conventional angioplasty or permanent stenting, and proving especially advantageous for individuals with extensive lesion lengths or severe limb ischemia. Through its integrated approach of drug dispensation and temporary structural reinforcement, the Esprit BTK System is intended to promote vessel recovery, decrease adverse events, and broaden therapeutic horizons for challenging PAD presentations.

Peripheral Artery Disease Market Company Landscape And Strategic Competition

Major companies operating in the peripheral artery disease market are Cardinal Health Inc., Vascular Solutions Inc., Bayer AG, Abbott Laboratories, Medtronic plc., Koninklijke Philips N.V. (Royal Philips), B. Braun Melsungen AG., Terumo Corporation, Edwards Lifesciences, Becton Dickinson and Company (BD), Boston Scientific Corporation Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., NuVasive Inc., Arjo AB, Penumbra Inc., BIOTRONIK SE and Co. KG, AngioDynamics Inc., Shockwave Medical Inc., Cardiovascular Systems Inc., Endologix LLC., LeMaitre Vascular Inc., Silk Road Medical Inc., WL Gore and Associates Inc., MicroPort Scientific Corporation, Bard Peripheral Vascular Inc., Avinger Inc.

Access The Complete Peripheral Artery Disease Market Report:

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Peripheral Artery Disease Market Geographic Distribution And Regional Opportunities

North America was the largest region in the peripheral artery disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral artery disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.